{
    "organizations": [],
    "uuid": "3bf475fba1da47ce5c5b6577539d68de27c044e3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mustang-bio-reports-q4-financial-r/brief-mustang-bio-reports-q4-financial-results-idUSASC09UB4",
    "ord_in_thread": 0,
    "title": "BRIEF-Mustang Bio Reports Q4 Financial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Fortress Biotech Inc:\n* MUSTANG BIO REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS\n* FORTRESS BIOTECH - ‍AS OF DEC 31, 2017, MUSTANG’S CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AND RESTRICTED CASH TOTALED $61.5 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-30T05:21:00.000+03:00",
    "crawled": "2018-03-30T00:35:04.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "fortress",
        "biotech",
        "inc",
        "mustang",
        "bio",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "recent",
        "corporate",
        "highlight",
        "fortress",
        "biotech",
        "dec",
        "mustang",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "restricted",
        "cash",
        "totaled",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}